Am. J. Respir. Crit. Care Med., Vol 152, No. 6, Dec 1995, 2097-2104.
Effect of chronic antigen and beta 2 agonist exposure on airway remodeling in guinea pigs
ZL Wang, BA Walker, TD Weir, MC Yarema, CR Roberts, M Okazawa, PD Pare and TR Bai
University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, Canada.
We recently reported that chronic exposure to fenoterol (FEN) in guinea
pigs increases in vivo and in vitro airway responsiveness to a degree
similar to that induced by chronic antigen (ovalbumin [OA]) exposure. We
hypothesized that these changes were due to airway inflammation and airway
remodeling. To trace newly recruited granulocytes as a marker of
inflammation and to detect DNA replication in resident airway wall cells,
the nucleotide 5'-bromo-2'-deoxyuridine (BrdU) was administered
intermittently over the six-wk period of chronic FEN and/or OA exposure.
Noncartilaginous airway dimensions were measured and the area fraction of
BrdU-immunoreactive and total nuclei in adventitia, smooth muscle, and
epithelium was determined by immunohistochemistry and point counting. The
proliferation index was defined as the ratio of the two area fractions in
each wall area. The adventitial areas of FEN- and OA- treated airways were
respectively 62 and 88% greater than those of control airways (p <
0.05). The inner wall areas were not increased. The smooth muscle cell and
epithelial cell proliferation index was increased after OA (smooth muscle
index: control, 2.7 +/- 1.1% [SEM]; OA, 23.0 +/- 3.7%; p < 0.02) but not
after FEN exposure, and there was an increased number of
BrdU-immunoreactive granulocytes in the adventitia and epithelium after OA
but not after FEN exposure. The increased in vivo airways responsiveness
produced by chronic OA or FEN exposure may be attributable to adventitial
thickening and increased in vitro muscle contractility, but the cellular
mechanisms underlying these and other airway wall responses are
different.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
I. S. T. Bos, R. Gosens, A. B. Zuidhof, D. Schaafsma, A. J. Halayko, H. Meurs, and J. Zaagsma
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
Eur. Respir. J.,
October 1, 2007;
30(4):
653 - 661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gosens, I. S. T. Bos, J. Zaagsma, and H. Meurs
Protective Effects of Tiotropium Bromide in the Progression of Airway Smooth Muscle Remodeling
Am. J. Respir. Crit. Care Med.,
May 15, 2005;
171(10):
1096 - 1102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tomic, C. C. Lassiter, J. D. Ritzenthaler, H. N. Rivera, and J. Roman
Anti-Tissue Remodeling Effects of Corticosteroids: Fluticasone Propionate Inhibits Fibronectin Expression in Fibroblasts
Chest,
January 1, 2005;
127(1):
257 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Reader, J. S. Tepper, E. S. Schelegle, M. C. Aldrich, L. F. Putney, J. W. Pfeiffer, and D. M. Hyde
Pathogenesis of Mucous Cell Metaplasia in a Murine Asthma Model
Am. J. Pathol.,
June 1, 2003;
162(6):
2069 - 2078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Vanacker, E. Palmans, R. A. Pauwels, and J. C. Kips
Effect of Combining Salmeterol and Fluticasone on the Progression of Airway Remodeling
Am. J. Respir. Crit. Care Med.,
October 15, 2002;
166(8):
1128 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. BAI, J. COOPER, T. KOELMEYER, P. D. PARE, and T. D. WEIR
The Effect of Age and Duration of Disease on Airway Structure in Fatal Asthma
Am. J. Respir. Crit. Care Med.,
August 1, 2000;
162(2):
663 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Hershenson and M. K. Abe
Mitogen-Activated Signaling in Airway Smooth Muscle . A Central Role for Ras
Am. J. Respir. Cell Mol. Biol.,
December 1, 1999;
21(6):
651 - 654.
[Full Text]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|